J&J's drug features a silicone-based drug delivery system that allows for the continuous release of gemcitabine chemotherapy and is administered into the bladder via a catheter. The FDA has ...

Following after in J&J's Taris-derived pipeline is TAR-210, an intravesical formulation of J&J's FGFR kinase inhibitor Balversa (erdafitinib), which started the phase 3 MoonRISe-1 trial in ...

This is Among the Best Airframes we Have seen in a While. It boasts an excellent maintenance pedigree, a generous maintenance budget, A Panel to die for, IO-550P Conversion, TKS, and an astonishing ...

Antoni Vilaseca Cabo, MD, discusses phase 1 data presented on TAR-210 for the treatment of patients with FGFR-altered high- and intermediate-risk non-muscle invasive bladder cancer. Sima Porten, MD, ...